Extracellular DNA affects NO content in human endothelial cells

Bulletin of Experimental Biology and Medicine

Volumn 149, Issue 2, 2010, Pages 196-200

  Efremova, L V ^a   Alekseeva, A Yu ^a   Konkova, M S ^a   Kostyuk, S V ^a   Ershova, E S ^a   Smirnova, T D ^a   Konorova, I L ^b   Veiko, N N ^a  

^a RESEARCH CENTRE FOR MEDICAL GENETICS   (Russian Federation)

^b RESEARCH CENTER OF NEUROLOGY   (Russian Federation)

Author keywords

CG DNA; endothelium; nitric oxide

Indexed keywords

CELL DNA; DNA FRAGMENT; ESTRADIOL; EXTRACELLULAR DNA; GENOMIC DNA; HYDROGEN PEROXIDE; NITRIC OXIDE; UNCLASSIFIED DRUG;

ARTICLE; ATHEROSCLEROSIS; CELL LEVEL; CONCENTRATION PROCESS; CONTROLLED STUDY; CULTURE MEDIUM; DINUCLEOTIDE REPEAT; DNA PROBE; DNA SEQUENCE; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HYPERTENSION; IN VITRO STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE;

ATHEROSCLEROSIS; CELLS, CULTURED; DNA; ENDOTHELIAL CELLS; ESTRADIOL; EXTRACELLULAR SPACE; GC RICH SEQUENCE; HUMANS; HYDROGEN PEROXIDE; HYPERTENSION; NITRIC OXIDE; SPECTROMETRY, FLUORESCENCE; UMBILICAL VEINS;

EID: 77956190316     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10517-010-0906-3     Document Type: Article

References (14)

1. NN Veiko NV Bulicheva OA Roginko, et al. 2008 Biomed Khimiya 54 1 78 93 1:CAS:528:DC%2BD1cXkslCitrc%3D
2. NN Veiko EA Kalashnikova SN Kokarovtseva, et al. 2006 Byull. Eksp. Biol. Med 142 10 410 414
3. NN Veiko NO Shubaeva SM Ivanova, et al. 2006 Byull. Eksp. Biol. Med No. 9 282 285
4. SV Kostyuk IA Zamulaeva RK Agapova, et al. 2008 Radiats. Biol. Radioekol. 48 5 13 1:CAS:528:DC%2BD1cXksFCjsL8%3D
5. Y Aida MJ Pabst 1990 J. Immunol. Methods 132 2 191 195 10.1016/0022-1759(90)90029-U 1:CAS:528:DyaK3cXmtFOqs70%3D 2170533
6. P Anker J Lyautey C Lederrey M Stroun 2001 Clin. Chim. Acta 313 1-2 143 146 10.1016/S0009-8981(01)00666-0 1:CAS:528:DC%2BD3MXnvFGqurw%3D 11694252
7. N Bulicheva O Fidelina N Mkrtumova, et al. 2008 Ann. N. Y. Acad. Sci. 1137 273 277 10.1196/annals.1448.023 1:CAS:528:DC%2BD1cXhtF2qurjO 18837959
8. LK Curtiss PS Tobias 2009 J. Lipid Res. 50 Suppl S340 S345 10.1194/jlr.R800056-JLR200 18980945
9. N Fitzner S Clauberg F Essmann, et al. 2008 Clin. Vaccine Immunol. 15 1 138 146 10.1128/CVI.00257-07 1:CAS:528:DC%2BD1cXkvVGjurs%3D 17978010
10. MH Lim 2007 Nat. Protoc. 2 2 408 415 10.1038/nprot.2007.43 1:CAS:528:DC%2BD2sXhtFGntbjO 17406602
11. MH Lim BA Wong WH Pitcock Jr, et al. 2006 J. Am. Chem. Soc. 128 44 14,364 14,373 10.1021/ja064955e 1:CAS:528:DC%2BD28XhtVKitbbN
12. M Magnusson R Tobes J Sancho E Pareja 2007 J. Immunol. 179 1 31 35 1:CAS:528:DC%2BD2sXmsF2hur0%3D 17579017
13. H Shimokawa K Morikawa 2005 J. Mol. Cell Cardiol. 39 5 725 732 10.1016/j.yjmcc.2005.07.007 1:CAS:528:DC%2BD2MXhtFCjsLnE 16122755
14. M van der Vaart PJ Pretorius 2008 Ann. N. Y. Acad. Sci. 1137 18 26 10.1196/annals.1448.022 18837919